You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

acarbose

Showing 1 - 25 of 52
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type 2 Diabetes, Blood Glucose Fluctuation Trial in Nanjing (Metformin plus pioglitazone, Acarbose)

Recruiting
  • Type 2 Diabetes
  • Blood Glucose Fluctuation
  • Metformin plus pioglitazone
  • Acarbose
  • Nanjing, China
    Nanjing First Hospital, Nanjing Medical Univesity
Nov 28, 2022

Aging Trial in Bronx (Acarbose, Placebo)

Completed
  • Aging
  • Acarbose
  • Placebo
  • Bronx, New York
    Montefiore Medical Center
Jan 20, 2022

Type 2 Diabetes Trial in China (Alogliptin, Acarbose, Metformin)

Completed
  • Type 2 Diabetes Mellitus
  • China, China
    CHINA
Apr 18, 2022

Other Specified Hypotension, Syncope Trial in Vancouver (Acarbose, Placebo)

Completed
  • Other Specified Hypotension
  • Syncope
  • Acarbose
  • Placebo
  • Vancouver, British Columbia, Canada
    Vancouver Coastal Health Research Institute, VGH Research Pavili
May 26, 2021

Healthy Volunteers Trial in Corvallis (Acarbose)

Recruiting
  • Healthy Volunteers
  • Acarbose
  • Corvallis, Oregon
    Department of Food Science and Technology
Apr 18, 2022

Type 2 Diabetes Trial in China (Dapagliflozin, Acarbose)

Terminated
  • Type 2 Diabetes Mellitus
  • Beijing, China
  • +19 more
Nov 23, 2021

Polycystic Ovary Syndrome Trial in Sherbrooke (Rosiglitazone, Acarbose)

Completed
  • Polycystic Ovary Syndrome
  • Sherbrooke, Quebec, Canada
    Université de Sherbrooke
Jan 4, 2022

Type 2 Diabetes Trial in China (INSULIN GLARGINE (HOE901), Insulin Glulisine, Biphasic insulin aspart 30)

Completed
  • Type 2 Diabetes Mellitus
  • INSULIN GLARGINE (HOE901)
  • +5 more
  • China, China
    CHINA
Apr 21, 2022

Type 2 Diabetes Trial in Seoul (Acarbose, Placebo acarbose, metformin)

Completed
Has Results
  • Type 2 Diabetes Mellitus
  • Acarbose
  • +2 more
  • Seoul, Korea, Republic of
    MedicalExcellence
Jul 31, 2020

Type 2 Diabetes Trial in Hamilton (drug, behavioral, other)

Completed
Has Results
  • Type 2 Diabetes Mellitus
  • insulin glargine
  • +4 more
  • Hamilton, Ontario, Canada
    McMaster University Medical Centre, Diabetes Care and Research P
May 10, 2020

Diabetes, Type 2 Trial in China (Acarbose, Metformin, Placebo)

Completed
  • Diabetes Mellitus, Type 2
  • Acarbose
  • +2 more
  • Hefei, Anhui, China
  • +28 more
Aug 3, 2020

Glucose Metabolism Disorders Trial in Hellerup (Acarbose, Placebo Oral Tablet, Exendin (9-39))

Completed
  • Glucose Metabolism Disorders
  • Acarbose
  • +3 more
  • Hellerup, Denmark
    Center for Diabetesresearch
Mar 25, 2020

Aging Trial in San Antonio (acarbose)

Completed
Has Results
  • Aging
  • acarbose
  • San Antonio, Texas
    UTHSCSA
Feb 21, 2019

Type 2 Diabetes, Obesity, Cognitive Impairment Trial in Nanjing (Liraglutid, Dapagliflozin, Acarbose)

Unknown status
  • Type 2 Diabetes Mellitus
  • +2 more
  • Nanjing, Jiangsu, China
    at Division of Endocrinology, the Affiliated Drum Tower Hospital
May 22, 2019

Type 2 Diabetes Trial in China (Metformin, Voglibose, Acarbose)

Completed
Has Results
  • Type 2 Diabetes Mellitus
  • Hefei, Anhui, China
  • +17 more
Feb 15, 2019

Type 2 Diabetes Trial (Sitagliptin phosphate, Comparator: Placebo, Acarbose)

Completed
Has Results
  • Type 2 Diabetes Mellitus
  • Sitagliptin phosphate
  • +3 more
  • (no location specified)
Jul 19, 2018

Type 2 Diabetes Trial in Nanjing (Saxagliptin, Acarbose)

Completed
  • Type 2 Diabetes
  • Nanjing, Jiangsu, China
    Department of Endocrinology, Zhongda Hospital. Institute of Diab
Jul 4, 2018

Type II Diabetes Trial in Korea, Republic of, Taiwan (ASP1941, acarbose, Placebo)

Terminated
  • Type II Diabetes Mellitus
  • Busan, Korea, Republic of
  • +14 more
Dec 13, 2018

Atherosclerosis Type 2 Diabetes Dipeptidyl Peptidase-4 Inhibitor GLP-1 Trial (Sitagliptin, Acarbose)

Unknown status
  • Atherosclerosis Type 2 Diabetes Mellitus Dipeptidyl Peptidase-4 Inhibitor GLP-1
  • (no location specified)
Jul 26, 2018

Type 2 Diabetes, Postprandial Hypotension Trial in Vancouver (Acarbose, Placebo)

Completed
  • Type 2 Diabetes
  • Postprandial Hypotension
  • Acarbose
  • Placebo
  • Vancouver, British Columbia, Canada
    VITALiTY Research Centre
Jun 27, 2017

Diabetes, Type 2 Trial in Worldwide (Glimepiride, Metformin, Pioglitazone)

Terminated
Has Results
  • Diabetes Mellitus, Type 2
  • Miami, Florida
  • +33 more
Sep 25, 2019

Type 2 Diabetes Trial in Shanghai (Saxagliptin, Acarbose)

Completed
Has Results
  • Type 2 Diabetes Mellitus
  • Shanghai, China
    Research Site
Mar 3, 2017

Polycystic Ovary Syndrome Trial in Shanghai (intensive lifestyle intervention, GLP-1 Receptor Agonists, Metformin)

Unknown status
  • Polycystic Ovary Syndrome
  • intensive lifestyle intervention
  • +3 more
  • Shanghai, Shanghai, China
    Renji Hospital Department of Endocrinology and Metabolism
Jun 20, 2017

Diabetes, Type 2, Obesity Trial in Beijing (Acarbose, Vildagliptin)

Unknown status
  • Diabetes Mellitus, Type 2
  • Obesity
  • Beijing, Beijing, China
    Beijing Pinggu Hospital
Dec 18, 2016

Coronary Heart Disease, Acute Coronary Syndrome, Impaired Glucose Tolerance Trial in China, Hong Kong (Acarbose, Matching

Completed
  • Coronary Heart Disease
  • +3 more
  • Acarbose
  • Matching Placebo
  • Hefei, Anhui, China
  • +176 more
Jul 21, 2017